Risk factors for mortality of patients with pneumonia caused by Acinetobacter baumannii and Pseudomonas aeruginosa

王飞,姚贝,张捷,贺蓓

2013-01-01

Abstract:OBJECTIVE To retrospectively investigate the risk factors associated the mortality of the patients with pneumonia caused by Acinetobacter baumannii and Pseudomonas aeruginosa,and focus on the impact of different antimicrobial regimens on the patients with A.baumannii pneumonia so as to guide the clinical treatment.METHODS We searched the qualified respiratory samples(including sputum and endotracheal aspirate) in the hospital during Jan 2012 to Aug 2012,and identified the cases with A.baumannii and/or P.aeruginosa positive isolates.The clinical data of the cases were reviewed and the cases were recruited when they were clinically diagnosed as pneumonia.The clinical and microbiological data of the patients were collected.logistic regression was applied to identify the risk factors of the mortality.RESULTS Totally 79 patients with pneumonia were enrolled in the study,including 46 patients infected with A.baumannii and 33 patients infected with P.aeruginosa;29 cases died with the mortality of 36.7%;the multivariate regression analysis showed that the respiratory frequency,blood urea nitrogen,sepsis,albumin level and use of antibiotics were the independent risk factors for the mortality of the patients with A.baumannii or P.aeruginosa pneumonia.The mortality of the patients with A.baumannii pneumonia was 50.0%,18.8% of the patients with P.aeruginosa pneumonia(P=0.004);A.baumannii infection was an independent factor for the increase in mortality(OR=4.33,P=0.007).Of all the A.baumannii strains,the multidrug-resistant A.baumannii accounted for 97.8%;the analysis of treatment program indicated that the use of single carbapenem for the primary treatment may increase the risk of mortality and that the use of other antibiotics had no significant impact on the mortality.CONCLUSION The severity of infection is the independent risk factor for the mortality of the patients with A.baumannii or P.aeruginosa pneumonia.The mortality of the patients with A.baumannii infections,especially the multidrug-resistant A.baumannii infections,is high.If A.baumannii infection or multidrug-resistant A.baumannii infection are concerned in clinic,the combination antimicrobial treatment or the compound containing sulbactam should be used as empirical therapy.